The Effect of Medicare Advantage on Hospital Admissions and Mortality
NBER Working Paper No. 19101
---- Acknowledgements ----
We would like to thank Dana Goldman for sharing his Part D Plan Characteristics file with us; Cheryl Sample at CMS for her rapid consideration of our data reuse request; seminar participants at Stanford, RAND, and USC for helpful comments; and Jack Boeglin for exceptional research assistance. We gratefully acknowledge funding from the National Institutes of Health. All errors are our own The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.
---- Disclosure of Financial Relationships for Michael E. Chernew ----
Consultant: AHIP, VBID Institute, Precision Health Economics LLC, TriZetto, Humana, AHRQ, Lewin, Carefirst, Welvie, Altarum
---- Disclosure of Financial Relationships for Daniel P. Kessler ----
Kessler reports speaking fees from America's Health Insurance Plans and Sutter Health; a grant from the AHIP Foundation; and consulting income from insurers, providers, and pharmaceutical manufacturers.